Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are ...

March 9 (Reuters) - Xenon Pharmaceuticals said on Monday its experimental epilepsy drug met the main goal of showing a statistically significant reduction in focal onset seizures in a late-stage trial ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

Add Yahoo as a preferred source to see more of our stories on Google. STORY: :: King's College London/UCL This MRI scan of a human brain shows in red an area that could be a potential lesion, and a ...

Xenon Pharmaceuticals said on Monday its experimental epilepsy drug met the main goal of showing a statistically significant reduction in focal onset seizures in a ​late-stage trial, sending its ...

There are just over 3 million Americans with epilepsy who experience seizures due to abnormal electrical activity in the brain. A smaller group of people also have seizures not caused by ...

Please provide your email address to receive an email when new articles are posted on . The study analyzed data from 1,224 individuals without and 27 individuals with late-onset epilepsy. Those with ...

The unpredictable, debilitating nature of a seizure can be frightening, for both the person experiencing it and anyone watching nearby. In that moment, control often slips away as muscles stiffen, ...

The present study was designed to evaluate the genetic mechanisms in patients with focal epileptiform discharges in the mid-temporal or central regions, an electroencephalographic abnormality of high ...

A team has found a new mechanism responsible for the abnormal development of neuronal connections in the mouse brain that leads to seizures and abnormal social behaviors. A team led by a biomedical ...